Renal Denervation in Moderate to Severe CKD
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Sympathetic activation contributes to the progression of CKD and is associated with adverse cardiovascular outcomes. Ablation of renal sympathetic nerves reduces sympathetic nerve activity and BP in patients with resistant hypertension and preserved renal function, but whether this approach is safe and effective in patients with an estimated GFR (eGFR) < 45 ml/min per 1.73 m(2) is unknown. We performed bilateral renal denervation in 15 patients with resistant hypertension and stage 3-4 CKD (mean eGFR, 31 ml/min per 1.73 m(2)). We used CO(2) angiography in six patients to minimize exposure to contrast agents. Estimated GFR remained unchanged after the procedure, irrespective of the use of CO(2) angiography. Mean baseline BP ± SD was 174 ± 22/91 ± 16 mmHg despite the use of 5.6 ± 1.3 antihypertensive drugs. Mean changes in office systolic and diastolic BP at 1, 3, 6, and 12 months were -34/-14, -25/-11, -32/-15, and -33/-19 mmHg, respectively. Night-time ambulatory BP significantly decreased (P<0.05), restoring a more physiologic dipping pattern. In conclusion, this study suggests a favorable short-term safety profile and beneficial BP effects of catheter-based renal nerve ablation in patients with stage 3-4 CKD and resistant hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a small clinical trial in 24 patients with kidney failure on haemodialysis confirmed the safety of the procedure in these patients and demonstrated that RDN resulted in significant reductions in DBP and SBP that persisted for at least 12 months64.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredIn the citing paper
“To this point only two small pilot studies have been conducted, both uncontrolled but successful, in renal hypertension, and in end-stage renal disease107–108.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Self-citationGlobal burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationRelation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
Anavekar, N. S., McMurray, J. J. V., Velazquez, E. J., Solomon, S. D., Kober, L., Rouleau, J.-L., White, H. D., Nordlander, R., Maggioni, A., Dickstein, K., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041365 · Cited by 1,917
Neural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Neural Control of Renal Function*
Kopp, U. C., & DiBona, G. F. (2020) · Reflex Control of the Circulation · doi:10.1201/9780367813338-17 · Cited by 1,126
Sega, R., Facchetti, R., Bombelli, M., Cesana, G., Corrao, G., Grassi, G., & Mancia, G. (2005) · Circulation · doi:10.1161/01.cir.0000160923.04524.5b · Cited by 1,009
Arterial wave reflections and survival in end-stage renal failure
London, G. M., Blacher, J., Pannier, B., Guérin, A. P., Marchais, S. J., & Safar, M. E. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.434 · Cited by 853
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0904179 · Cited by 772
Self-citationSymplicity HTN-1 Investigators (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163014 · Cited by 744
Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010112 · Cited by 719
Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.991869 · Cited by 573
Self-citationZoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
The prevalence of anemia in patients with chronic kidney disease
McClellan, W., Aronoff, S. L., Bolton, W. K., Hood, S., Lorber, D. L., Tang, K. L., Tse, T. F., Wasserman, B., & Leiserowitz, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x2763 · Cited by 474
Witkowski, A., Prejbisz, A., Florczak, E., Kądziela, J., Śliwiński, P., Bieleń, P., Michałowska, I., Kabat, M., Warchoł, E., Januszewicz, M., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173799 · Cited by 460
Self-citationSympathetic Activation in Chronic Renal Failure
Schlaich, M. P., Socratous, F., Hennebry, S., Eikelis, N., Lambert, E. A., Straznicky, N., Esler, M. D., & Lambert, G. W. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040402 · Cited by 408
Self-citationAbramson, J. L., Jurkovitz, C. T., Vaccarino, V., Weintraub, W. S., & Mcclellan, W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00109.x · Cited by 336
Fagard, R. H., Thijs, L., Staessen, J. A., Clement, D. L., De Buyzere, M. L., & De Bacquer, D. A. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.9 · Cited by 324
ZOCCALI, C., MALLAMACI, F., BENEDETTO, F. A., TRIPEPI, G., PARLONGO, S., CATALIOTTI, A., CUTRUPI, S., GIACONE, G., BELLANUOVA, I., COTTINI, E., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271508 · Cited by 320
Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure
Grassi, G., Quarti-Trevano, F., Seravalle, G., Arenare, F., Volpe, M., Furiani, S., Dell'Oro, R., & Mancia, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164780 · Cited by 311
Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept
Schlaich, M. P., Sobotka, P. A., Krum, H., Whitbourn, R., Walton, A., & Esler, M. D. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138610 · Cited by 249
Self-citationRahman, M., Pressel, S., Davis, B. R., Nwachuku, C., Wright, J. T., Whelton, P. K., Barzilay, J., Batuman, V., Eckfeldt, J. H., Farber, M. A., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00005 · Cited by 227
Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.
Marchais, S. J., Guerin, A. P., Pannier, B. M., Levy, B. I., Safar, M. E., & London, G. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.6.876 · Cited by 221
Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call
Koomans, H. A., Blankestijn, P. J., & Joles, J. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113320.57127.b9 · Cited by 205
Cardiovascular disease in end-stage renal disease patients
Collins, A. J., Li, S., Ma, J. Z., & Herzog, C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27392 · Cited by 186
The Sympathetic Nervous System and Hypertension: Recent Developments
DiBona, G. F. (2004) · Hypertension · doi:10.1161/01.hyp.0000113047.47711.fa · Cited by 175
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?
Schlaich, M. P., Straznicky, N. E., Grima, M. T., Sari, C. I., Dawood, T., Mahfoud, F., Lambert, É., Chopra, R., Socratous, F., Hennebry, S. C., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328344db3a · Cited by 150
Self-citationCoghill, N. F., Revans, R. W., ULYATT, F. M., & Ulyatt, K. (1970) · PubMed · Cited by 126
Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome
Herzog, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.17.x · Cited by 119
Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients
Redaelli, B., Cavalli, A., Latini, R., Maggioni, A. P., Mingardi, G., Osculati, G., Sforzini, S., Tognoni, G., Vincenti, A., Volpi, A., et al. (1988) · The Lancet · Cited by 108
Rump, L. C., Amann, K., Orth, S., & Ritz, E. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.11.1735 · Cited by 97
Li, S., & Collins, A. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00425.x · Cited by 86
Covic, A. C., Mardare, N., Gusbeth–Tatomir, P., Prisadă, O., Sascău, R. A., & Goldsmith, D. J. A. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl307 · Cited by 71
Neurogenic factors in renal hypertension
Campese, V. M., & Król, E. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0016-3 · Cited by 56
Tsioufis, C. P., Tzioumis, C., Marinakis, N., Toutouzas, K. P., Tousoulis, D. M., Kallikazaros, I. E., Stefanadis, C., & TOUTOUZAS, P. K. (2003) · Nephron Clinical Practice · doi:10.1159/000069546 · Cited by 36
Renal Sympathetic Denervation: Renal Function Concerns
Petidis, K., Anyfanti, P., & Doumas, M. N. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.178145 · Cited by 29
Renal sympathetic nerves modulate erythropoietin plasma levels after transient hemorrhage in rats
Ditting, T., Hilgers, K. F., Stetter, A., Linz, P. R., Schönweiss, C., & Veelken, R. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00267.2007 · Cited by 23
The anemia of microgravity and recumbency
Robertson, D. J., Krantz, S. B., & Biaggioni, I. (1994) · Acta Astronautica · doi:10.1016/0094-5765(94)90118-x · Cited by 23
Cited by
Krum, H., Schlaich, M. P., Sobotka, P. A., Böhm, M., Mahfoud, F., Rocha-Singh, K., Katholi, R., & Esler, M. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62192-3 · Cited by 619
Self-citationThe Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Self-citationEsler, M. D., Krum, H., Schlaich, M., Schmieder, R. E., Böhm, M., & Sobotka, P. A. (2012) · Circulation · doi:10.1161/circulationaha.112.130880 · Cited by 461
Self-citationHering, D., Lambert, E. A., Marusic, P., Walton, A. S., Krum, H., Lambert, G. W., Esler, M. D., & Schlaich, M. P. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00194 · Cited by 356
Self-citationNew approaches in the treatment of hypertension
Oparil, S., & Schmieder, R. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.303603 · Cited by 276
Metadata
- Authors
- Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Böhm, M., Cremers, B., Esler, M. D., & Schlaich, M. P.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- Universitätsklinikum des Saarlandes (DE)
- The Alfred Hospital (AU)
- University of Minnesota (US)
- Corresponding author
- Hering, Dagmara
- Lambert, Gavin W.
- Esler, Murray D.
- Schlaich, Markus P.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-07
- Volume
- 23
- Issue
- 7
- Pages
- 1250-1257
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3380649
- OpenAlex
- W2099897414
- Cited by
- 361
- References
- 44
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 13 · 2023: 15 · 2022: 8 · 2021: 11 · 2020: 13 · 2019: 10 · 2018: 7 · 2017: 25 · 2016: 21 · 2015: 37 · 2014: 72 · 2013: 82 · 2012: 27
- FWCI
- 44.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Keywords
- renal denervation, chronic kidney disease, resistant hypertension, renal sympathetic nerves, blood pressure reduction, ambulatory blood pressure, CO2 angiography, estimated glomerular filtration rate, cardiovascular risk
- MeSH terms
- Aged, Chronic Disease, Female, Humans, Hypertension, Renal, Kidney, Kidney Diseases, Male, Middle Aged, Pilot Projects, Severity of Illness Index, Sympathectomy, Comorbidity, Treatment Outcome, Catheter Ablation, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.